← Back to directory

Adrian L. Harris

Researcher Next ID · RN-024552

Researcher · Biochemistry, Genetics and Molecular Biology

University of Liverpool

Liverpool, United Kingdom

Not currently recruitingFunding unknown
Works count
2,091
Citation count
158,703
H-index
189
i10-index
1,102

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Cancer, Hypoxia, and Metabolism
Angiogenesis and VEGF in Cancer
RNA modifications and cancer
HER2/EGFR in Cancer Research
Cancer, Lipids, and Metabolism

Publications

  • Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles · 2024 · https://doi.org/10.1002/jev2.12404

  • Consensus guidelines for the use and interpretation of angiogenesis assays

    Angiogenesis · 2018 · https://doi.org/10.1007/s10456-018-9613-x

  • Imaging biomarker roadmap for cancer studies

    Nature Reviews Clinical Oncology · 2016 · https://doi.org/10.1038/nrclinonc.2016.162

  • Acetyl-CoA Synthetase 2 Promotes Acetate Utilization and Maintains Cancer Cell Growth under Metabolic Stress

    Cancer Cell · 2015 · https://doi.org/10.1016/j.ccell.2014.12.002

  • Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis

    Nanomedicine Nanotechnology Biology and Medicine · 2011 · 10.1016/j.nano.2011.04.003

  • Aberrant succination of proteins in fumarate hydratase‐deficient mice and HLRCC patients is a robust biomarker of mutation status

    The Journal of Pathology · 2011 · https://doi.org/10.1002/path.2932

  • Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer

    PLoS ONE · 2011 · https://doi.org/10.1371/journal.pone.0020980

  • Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies

    Journal of Enzyme Inhibition and Medicinal Chemistry · 2009 · https://doi.org/10.1080/14756360902784425

  • Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma

    British Journal of Haematology · 2008 · https://doi.org/10.1111/j.1365-2141.2008.07077.x

  • Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series

    Clinical Cancer Research · 2007 · 10.1158/1078-0432.ccr-06-2765

  • Delta-like 4 Notch Ligand Regulates Tumor Angiogenesis, Improves Tumor Vascular Function, and Promotes Tumor Growth In vivo

    Cancer Research · 2007 · https://doi.org/10.1158/0008-5472.can-07-0969

  • Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor–Positive Breast Carcinomas Through Genomic Grade

    Journal of Clinical Oncology · 2007 · https://doi.org/10.1200/jco.2006.07.1522

  • Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

    Journal of Clinical Oncology · 2006 · 10.1200/jco.2006.05.9584

  • Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer

    JNCI Journal of the National Cancer Institute · 2006 · 10.1093/jnci/djj329

  • Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis

    JNCI Journal of the National Cancer Institute · 2006 · https://doi.org/10.1093/jnci/djj052

  • Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression

    British Journal of Cancer · 2004 · https://doi.org/10.1038/sj.bjc.6602245

  • Differential Function of the Prolyl Hydroxylases PHD1, PHD2, and PHD3 in the Regulation of Hypoxia-inducible Factor

    Journal of Biological Chemistry · 2004 · 10.1074/jbc.m406026200

  • Breast cancer classification and prognosis based on gene expression profiles from a population-based study

    Proceedings of the National Academy of Sciences · 2003 · https://doi.org/10.1073/pnas.1732912100

  • Hypoxia — a key regulatory factor in tumour growth

    Nature reviews. Cancer · 2002 · https://doi.org/10.1038/nrc704

  • The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages

    American Journal Of Pathology · 2000 · 10.1016/s0002-9440(10)64554-3

  • Hypoxia-inducible expression of tumor-associated carbonic anhydrases.

    PubMed · 2000

  • Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions.

    PubMed · 1999

  • Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth

    Proceedings of the National Academy of Sciences · 1997 · 10.1073/pnas.94.15.8104

  • Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma.

    PubMed · 1996

  • Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation

    European Journal of Cancer · 1996 · 10.1016/s0959-8049(96)00379-6

  • CARBOPLATIN OR CISPLATIN?

    The Lancet · 1988 · 10.1016/s0140-6736(88)92709-2

Current projects

    No projects listed.